COM:VIFORPHARMA
CSL Vifor
- Stock
Last Close
165.35
22/12 16:31
Volume Today
21.85K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|---|
revenue | 3.36B - | 3.42B 1.69% | 3.79B 10.99% | 4.12B 8.62% | 1.34B 67.41% | 1.58B 18.08% | 1.88B 18.47% | 1.71B 9.15% | 1.82B 6.98% | |
cost of revenue | 2.17B - | 2.18B 0.37% | 2.33B 7.00% | 2.48B 6.39% | 517.90M 79.11% | 648.70M 25.26% | 761.50M 17.39% | 701.20M 7.92% | 671.80M 4.19% | |
gross profit | 1.19B - | 1.24B 4.10% | 1.46B 17.99% | 1.64B 12.18% | 824.20M 49.72% | 936M 13.56% | 1.12B 19.22% | 1.00B 9.99% | 1.15B 14.77% | |
selling and marketing expenses | 136.66M - | 140.52M 2.83% | 148.82M 5.90% | 173.79M 16.78% | 434M 149.72% | 410.80M 5.35% | 455.30M 10.83% | 403.80M 11.31% | 399.20M 1.14% | |
general and administrative expenses | 73.17M - | 72.22M 1.30% | 70.88M 1.86% | 106.78M 50.66% | 162.40M 52.08% | 155.90M 4.00% | 145.70M 6.54% | 155.70M 6.86% | 144.70M 7.06% | |
selling general and administrative expenses | 209.83M - | 212.74M 1.39% | 219.69M 3.27% | 280.58M 27.71% | 596.40M 112.56% | 566.70M 4.98% | 601M 6.05% | 559.50M 6.91% | 543.90M 2.79% | |
research and development expenses | 185.10M - | 206.40M 11.51% | 228.30M 10.61% | 250M 9.51% | 252.70M 1.08% | |||||
other expenses | 596.35M - | 664.85M 11.49% | 795.85M 19.70% | 1.00B 25.97% | -91.60M 109.14% | -64.60M 29.48% | -38.40M 40.56% | -65.40M 70.31% | -66.10M 1.07% | |
cost and expenses | 2.98B - | 3.06B 2.67% | 3.35B 9.51% | 3.76B 12.45% | 1.21B 67.90% | 1.36B 12.37% | 1.55B 14.38% | 1.45B 6.90% | 1.40B 2.98% | |
operating expenses | 806.18M - | 877.59M 8.86% | 1.02B 15.72% | 1.28B 26.35% | 689.90M 46.23% | 708.50M 2.70% | 790.90M 11.63% | 744.10M 5.92% | 730.50M 1.83% | |
interest expense | 31.91M - | 24.99M 21.66% | 21.81M 12.74% | 30.67M 40.62% | 25.20M 17.83% | 6.80M 73.02% | 9M 32.35% | 7.70M 14.44% | 9M 16.88% | |
ebitda | 432.16M - | 431.36M 0.19% | 468.44M 8.60% | 413.63M 11.70% | 1.32B 219.10% | 348.30M 73.61% | 419M 20.30% | 678.80M 62.00% | 519.60M 23.45% | |
operating income | 356.49M - | 354.73M 0.49% | 381.85M 7.64% | 286.06M 25.08% | 1.17B 310.37% | 184.20M 84.31% | 204M 10.75% | 394.40M 93.33% | 199.70M 49.37% | |
depreciation and amortization | 75.67M - | 76.63M 1.26% | 86.60M 13.01% | 127.57M 47.31% | 146M 14.45% | 164.10M 12.40% | 215M 31.02% | 284.40M 32.28% | 319.90M 12.48% | |
total other income expenses net | 6.77M - | 2.54M 62.49% | 47.13M 1,754.90% | 49.47M 4.96% | -1.05B 2,219.10% | 85.20M 108.13% | 105.60M 23.94% | -129.70M 222.82% | 112M 186.35% | |
income before tax | 363.26M - | 357.27M 1.65% | 428.98M 20.07% | 335.53M 21.78% | 125.60M 62.57% | 269.40M 114.49% | 309.60M 14.92% | 264.70M 14.50% | 311.70M 17.76% | |
income tax expense | 28.42M - | 45.29M 59.35% | 58.98M 30.23% | 11.77M 80.05% | 1.60M 86.40% | 25M 1,462.50% | 35.90M 43.60% | 27.10M 24.51% | 46.30M 70.85% | |
net income | 334.84M - | 311.99M 6.83% | 370.00M 18.60% | 323.76M 12.50% | 124M 61.70% | 244.40M 97.10% | 273.70M 11.99% | 237.60M 13.19% | 265.40M 11.70% | |
weighted average shs out | 64.79M - | 64.78M 0.02% | 64.79M 0.03% | 64.77M 0.04% | 64.81M 0.07% | 65.02M 0.32% | 65.05M 0.05% | 65.03M 0.03% | 64.86M 0.25% | |
weighted average shs out dil | 64.91M - | 64.88M 0.04% | 64.91M 0.04% | 64.87M 0.06% | 64.92M 0.08% | 65.02M 0.15% | 65.05M 0.05% | 65.03M 0.03% | 64.86M 0.25% | |
eps | 5.17 - | 4.82 6.77% | 5.71 18.46% | 5 12.43% | 1.91 61.80% | 3.76 96.86% | 4.21 11.97% | 3.65 13.30% | 4.09 12.05% | |
epsdiluted | 5.16 - | 4.81 6.78% | 5.70 18.50% | 4.99 12.46% | 1.91 61.72% | 3.76 96.86% | 4.21 11.97% | 3.65 13.30% | 4.09 12.05% |
All numbers in (except ratios and percentages)